Diabetes - Perspectives in Drug Therapy
Diabetes - Perspectives in Drug Therapy
The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.
Preface. Targeting type 2 diabetes. Dual acting and pan-PPAR activators as potential anti-diabetic therapies. GLP-agonists and Dipeptidyl-Peptidase IV Inhibitors. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. SGLT Inhibitors as New Therapeutic Tools in the Treatment of Diabetes. Inhibitors of 11b-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy. Nampt and its potential role in inflammation and type 2 diabetes . Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance. Overcoming Insulin Resistance with Ciliary Neurotrophic Factor. Thermogenesis and related metabolic targets in anti-diabetic therapy. Interleukin targeted therapy for metabolic syndrome and type 2 diabetes. Fructose-1, 6-Bisphosphatase Inhibitors for Reducing Excessive Endogenous Glucose Production in Type 2 Diabetes. AMP-activated protein kinase and metabolic control. Mitochondria as potential targets in antidiabetic therapy . Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects<br />
Schwanstecher, Mathias
| ISBN | 978-3-642-26742-0 |
|---|---|
| Artikelnummer | 9783642267420 |
| Medientyp | Buch |
| Copyrightjahr | 2013 |
| Verlag | Springer, Berlin |
| Umfang | XIII, 408 Seiten |
| Abbildungen | XIII, 408 p. 69 illus. |
| Sprache | Englisch |
